Stock of the Day

Thermo Fisher Scientific (TMO)

$404.82

+$6.46 (+1.6%)

Market Cap: $152.90B

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

• The current stock price is around $500, reflecting a significant adjustment from previous highs, which may present a buying opportunity for investors looking for value.
• Thermo Fisher Scientific Inc. has a strong dividend payout ratio of approximately 10%, indicating a commitment to returning value to shareholders while maintaining financial stability.
• Recent analyst ratings show a predominance of buy ratings, with seventeen analysts recommending the stock, suggesting strong market confidence in the company's future performance.
• The company operates in diverse sectors, including life sciences and biopharma services, which positions it well to capitalize on growth opportunities across various markets.
• With a moderate buy average rating and a price target of around $605.30, there is potential for price appreciation, making it an attractive option for growth-oriented investors.

Thermo Fisher Scientific Bear Case

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

• Recent price target reductions by several analysts, including a drop to $500 from $585 by Evercore ISI, may indicate concerns about the company's near-term performance.
• The stock has a relatively low dividend yield of 0.43%, which may not be appealing for income-focused investors seeking higher returns from dividends.
• Corporate insiders own only 0.33% of the stock, which could suggest a lack of confidence from those closest to the company regarding its future prospects.
• Market volatility and economic uncertainties could impact the company's performance, especially in sectors heavily influenced by regulatory changes and funding availability.
• Despite a strong market position, the competitive landscape in life sciences and diagnostics is intense, which may pressure margins and growth rates in the future.

Recent News

• Traders Eye a Breakout in Thermo Fisher Scientific (TMO) Amid Market Undercurrents (msn.com)
• Bank of America Securities Sticks to Its Buy Rating for Thermo Fisher (TMO) (theglobeandmail.com)
• Thermo Fisher announces launch of Orbitrap Astral Zoom, Orbitrap Excedion Pro (msn.com)
• Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to ... (gurufocus.com)
• Q1 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks (msn.com)
• Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued? (seekingalpha.com)
• Thermo Fisher Is Strengthening Its Long-Term Advantage (seekingalpha.com)